Simple measures to prevent post-ERCP pancreatitis?

Gut

Volumn 57, Issue 9, 2008, Pages 1197-1198

  Testoni, Pier Alberto ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DICLOFENAC; GABEXATE; HEPARIN; INDOMETACIN; INTERLEUKIN 10; OCTREOTIDE; SOMATOSTATIN;

CLINICAL TRIAL; DRUG EFFICACY; DRUG INHIBITION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EVIDENCE BASED MEDICINE; HIGH RISK PATIENT; HUMAN; NOTE; PANCREATITIS; PRIORITY JOURNAL;

ACUTE DISEASE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CLINICAL TRIALS AS TOPIC; HUMANS; META-ANALYSIS AS TOPIC; PANCREATITIS; REVIEW LITERATURE AS TOPIC;

EID: 50249154273     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2008.153080     Document Type: Note

References (20)

1. Testoni PA. Facts and fiction in the pharmacological prevention of post-ERCP pancreatitis: a never-ending story [editorial]. Gastrointest Endosc 2006;64:732-34.
2. Lung E. The use of somatostatin or octreotide to prevent post-ERCP pancreatitis: a meta-analysis of randomized, controlled trials [abstract). Gastrointest Endosc 2004;59:AB 107.
3. Andriulli A, Leandro G, Niro G, et al. Pharmacological treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 2000;51:1-7.
4. Andriulli A, Clemente R, Solmi L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 2002;56:488-95.
5. Andriulli A, Caruso N, Quitadamo M,ζet al. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP 2003;4:41-8.
6. Andriulli A, Leandro G, Federici T, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest Endosc 2007;65:624- 32.
7. Rudin D, Kiss A, Wetz RV, et al. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials. J Gastroenterol Hepatol 2007;22:977-63.
8. Zheng M, Chen Y, Yang X, et al. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterol 2007;7:6-13.
9. Testoni PA, Mariani A, Masci E, et al. Frequency of post-ERCP pancreatitis in a single tertiary referral centre with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness. Dig liver Dis 2006:38:588-95.
10. Zheng M, Bai J, Yuan B, et al. Meta-analysis of prophylactic corticosteroids use in post-ERCP pancreatitis. BMC Gastroenterol 2008:8:6-13.
11. Masci E. Mariani A, Curioni S, et al. Risk factors for pancreatitis following endoscopic retrograde cholangio-pancreatography: a meta-analysis. Endoscopy 2003;35:830-4.
12. Rabenstein T, Roggenbuck S, Framke B, et al. Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis following endoscopic retrograde cholangio-pancreatography? Gastrointest Endosc 2002;55:476-63.
13. Deviere J, Le Moine O, Van Laethem JL, et al. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001;120:498-505.
14. Murray B, Carter R, Imrie C, et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangio- pancreatography. Gastroenterology 2003;124:1786-91.
15. Sotousdehmanesh R, Khatibian M, Kolahdoozan S, et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 2007;102:978-83.
16. Khoshbaten M, Khorram H, Madad L, et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastronterol Hepatol 2007,5: Epub ahead of print
17. Montano Loza A, Rodriguez Lomeli X, Garcia Correa J, et al. Effect of rectal administration of indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes. Rev Esp Enterm Dig 2007;99:330-6.
18. Cheon YK, Cho KB. Watkins JL, et al. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. Gastrointest Endosc 2007;66:1126-32.
19. Bmunzer BJ, Waljee AK, Elta GH, et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut 2008:57:1262-7.
20. Freeman ML Pancreatic stents for prevention of post-endoscopic cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007;5:1354-65.